-
Je něco špatně v tomto záznamu ?
Measuring Mitochondrial Substrate Flux in Recombinant Perfringolysin O-Permeabilized Cells
M. Elkalaf, K. Vaněčková, P. Staňková, Z. Červinková, J. Polák, O. Kučera
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem, audiovizuální média
PubMed
34459820
DOI
10.3791/62902
Knihovny.cz E-zdroje
- MeSH
- bakteriální toxiny * metabolismus MeSH
- buněčné dýchání * MeSH
- hemolyziny metabolismus MeSH
- mitochondrie metabolismus MeSH
- spotřeba kyslíku MeSH
- Publikační typ
- audiovizuální média MeSH
- časopisecké články MeSH
- práce podpořená grantem MeSH
Mitochondrial substrate flux is a distinguishing characteristic of each cell type, and changes in its components such as transporters, channels, or enzymes are involved in the pathogenesis of several diseases. Mitochondrial substrate flux can be studied using intact cells, permeabilized cells, or isolated mitochondria. Investigating intact cells encounters several problems due to simultaneous oxidation of different substrates. Besides, several cell types contain internal stores of different substrates that complicate results interpretation. Methods such as mitochondrial isolation or using permeabilizing agents are not easily reproducible. Isolating pure mitochondria with intact membranes in sufficient amounts from small samples is problematic. Using non-selective permeabilizers causes various degrees of unavoidable mitochondrial membrane damage. Recombinant perfringolysin O (rPFO) was offered as a more appropriate permeabilizer, thanks to its ability to selectively permeabilize plasma membrane without affecting mitochondrial integrity. When used in combination with microplate respirometry, it allows testing the flux of several mitochondrial substrates with enough replicates within one experiment while using a minimal number of cells. In this work, the protocol describes a method to compare mitochondrial substrate flux of two different cellular phenotypes or genotypes and can be customized to test various mitochondrial substrates or inhibitors.
Department of Internal Medicine University Hospital Kralovske Vinohrady
Department of Pathophysiology 3rd Faculty of Medicine Charles University
Department of Physiology Faculty of Medicine in Hradec Králové Charles University
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22003930
- 003
- CZ-PrNML
- 005
- 20220127145719.0
- 007
- ta
- 008
- 220113s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3791/62902 $2 doi
- 035 __
- $a (PubMed)34459820
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Elkalaf, Moustafa $u Department of Physiology, Faculty of Medicine in Hradec Králové, Charles University; Department of Pathophysiology, Third Faculty of Medicine, Charles University; elkalafm@lfhk.cuni.cz
- 245 10
- $a Measuring Mitochondrial Substrate Flux in Recombinant Perfringolysin O-Permeabilized Cells / $c M. Elkalaf, K. Vaněčková, P. Staňková, Z. Červinková, J. Polák, O. Kučera
- 520 9_
- $a Mitochondrial substrate flux is a distinguishing characteristic of each cell type, and changes in its components such as transporters, channels, or enzymes are involved in the pathogenesis of several diseases. Mitochondrial substrate flux can be studied using intact cells, permeabilized cells, or isolated mitochondria. Investigating intact cells encounters several problems due to simultaneous oxidation of different substrates. Besides, several cell types contain internal stores of different substrates that complicate results interpretation. Methods such as mitochondrial isolation or using permeabilizing agents are not easily reproducible. Isolating pure mitochondria with intact membranes in sufficient amounts from small samples is problematic. Using non-selective permeabilizers causes various degrees of unavoidable mitochondrial membrane damage. Recombinant perfringolysin O (rPFO) was offered as a more appropriate permeabilizer, thanks to its ability to selectively permeabilize plasma membrane without affecting mitochondrial integrity. When used in combination with microplate respirometry, it allows testing the flux of several mitochondrial substrates with enough replicates within one experiment while using a minimal number of cells. In this work, the protocol describes a method to compare mitochondrial substrate flux of two different cellular phenotypes or genotypes and can be customized to test various mitochondrial substrates or inhibitors.
- 650 12
- $a bakteriální toxiny $x metabolismus $7 D001427
- 650 12
- $a buněčné dýchání $7 D019069
- 650 _2
- $a hemolyziny $x metabolismus $7 D006460
- 650 _2
- $a mitochondrie $x metabolismus $7 D008928
- 650 _2
- $a spotřeba kyslíku $7 D010101
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a audiovizuální média $7 D059040
- 700 1_
- $a Vaněčková, Karolína $u Department of Physiology, Faculty of Medicine in Hradec Králové, Charles University; Department of Pathophysiology, Third Faculty of Medicine, Charles University
- 700 1_
- $a Staňková, Pavla $u Department of Physiology, Faculty of Medicine in Hradec Králové, Charles University
- 700 1_
- $a Červinková, Zuzana $u Department of Physiology, Faculty of Medicine in Hradec Králové, Charles University
- 700 1_
- $a Polák, Jan $u Department of Pathophysiology, Third Faculty of Medicine, Charles University; Department of Internal Medicine, University Hospital Kralovske Vinohrady
- 700 1_
- $a Kučera, Otto $u Department of Physiology, Faculty of Medicine in Hradec Králové, Charles University
- 773 0_
- $w MED00190569 $t Journal of visualized experiments : JoVE $x 1940-087X $g č. 174 (2021)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34459820 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127145716 $b ABA008
- 999 __
- $a ok $b bmc $g 1751405 $s 1155079
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $c 174 $e 20210813 $i 1940-087X $m Journal of visualized experiments $n J. vis. exp. $x MED00190569
- LZP __
- $a Pubmed-20220113